02197

1.34010.67%
PL

Peng Liang

Founder, Chief Scientific Officer & Chairman of the Board

Dr. Peng Liang, Ph.D. is Co-Founder, President and Chairman at Sichuan Clover Biopharmaceuticals, Inc. Dr. Liang is Founder and CEO of GenHunter Corporation. He serves as Chairman of the Board at Clover Biopharmaceuticals, Ltd. and serves as its Director and Chief Scientific Officer since October 31, 2018. He is Founder of Clover Biopharmaceuticals, Ltd. He is Inventor of Trimer-Tag© technology. He is Co-inventor of Differential Display technology. He discovered IL-24 and its receptors (licensed to Wyeth). He is Winner of 1998 Molecular Bioanalytics Prize from the German Society of Biological Chemistry and Molecular Biology. He has Published 75+ original research papers in peer-reviewed journals. He was Associate Professor of Cancer Biology, Vanderbilt University. He was Postdoc from Harvard Medical School. He holds PhD in Biochemistry from University of Illinois and BS in Biology from Beijing University.

Positions